Revelation Biosciences, Inc. is the subject of a Schedule 13G reporting that Sabby Volatility Warrant Master Fund, Ltd., Sabby Management, LLC, and Hal Mintz together beneficially own 605,702 shares of its common stock, representing 9.56% of the class as of the event date of 12/31/2025. The filing shows these shares are held with shared voting and dispositive power and no sole voting or dispositive power. The reporting persons certify that the securities were not acquired and are not held for the purpose of changing or influencing control of Revelation Biosciences.
Positive
None.
Negative
None.
Insights
Sabby entities report a passive 9.56% stake in Revelation Biosciences.
The Schedule 13G shows Sabby Volatility Warrant Master Fund, Ltd., Sabby Management, LLC, and Hal Mintz collectively beneficially owning 605,702 common shares of Revelation Biosciences, equal to 9.56% of the outstanding class. All three reporting persons list zero sole voting and dispositive power and the same shared voting and dispositive power over these shares.
Because the stake is reported on a Schedule 13G rather than 13D, the group certifies that the position was not acquired to change or influence control of the company. That indicates a passive investment posture under the rules cited, although future intent would depend on any subsequent filings.
The date of the reportable event is 12/31/2025, giving investors a snapshot of ownership at that point in time. Any material changes in this 9.56% position, or a shift from a 13G to a 13D filing status in later periods, would typically be reflected in updated beneficial ownership disclosures.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
REVELATION BIOSCIENCES, INC.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
76135L705
(CUSIP Number)
12/31/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
76135L705
1
Names of Reporting Persons
SABBY MANAGEMENT, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
605,702.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
605,702.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
605,702.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.6 %
12
Type of Reporting Person (See Instructions)
CO
SCHEDULE 13G
CUSIP No.
76135L705
1
Names of Reporting Persons
Hal Mintz
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
FLORIDA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
605,702.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
605,702.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
605,702.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.6 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP No.
76135L705
1
Names of Reporting Persons
Sabby Volatility Warrant Master Fund, Ltd.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
605,702.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
605,702.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
605,702.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.6 %
12
Type of Reporting Person (See Instructions)
CO
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
REVELATION BIOSCIENCES, INC.
(b)
Address of issuer's principal executive offices:
4660 LAJOLLA VILLAGE DRIVE, SUITE 100, SAN DIEGO, CALIFORNIA, 92122
Address or principal business office or, if none, residence:
Sabby Volatility Warrant Master Fund, Ltd.
c/o Captiva (Cayman) Ltd
Governors Square, Bldg 4, 2nd Floor
23 Lime Tree Bay Avenue
P.O. Box 32315
Grand Cayman KY1-1209
Cayman Islands
Sabby Management, LLC
1011 Links Dr.
Miami Beach, FL 33109
Hal Mintz
c/o Sabby Management, LLC
1011 Links Dr.
Miami Beach, FL 33109
(c)
Citizenship:
Sabby Volatility Warrant Master Fund, Ltd. - Cayman Islands
Sabby Management, LLC - Delaware, USA
Hal Mintz - USA
(d)
Title of class of securities:
Common Stock
(e)
CUSIP No.:
76135L705
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
605,702
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
How many Revelation Biosciences (REVB) shares do the Sabby entities report owning?
The filing reports that Sabby Volatility Warrant Master Fund, Ltd., Sabby Management, LLC, and Hal Mintz beneficially own a total of 605,702 shares of Revelation Biosciences common stock.
What percentage of Revelation Biosciences’ common stock is owned by the Sabby group?
The reported beneficial ownership is 9.56% of the outstanding common stock for each of Sabby Volatility Warrant Master Fund, Ltd., Sabby Management, LLC, and Hal Mintz.
Is the Sabby stake in Revelation Biosciences reported as passive or active?
The position is reported on a Schedule 13G, and the signatories certify that the securities were not acquired and are not held for the purpose of changing or influencing control of Revelation Biosciences.
Who are the reporting persons in the Revelation Biosciences (REVB) Schedule 13G?
The reporting persons are Sabby Volatility Warrant Master Fund, Ltd., Sabby Management, LLC, and Hal Mintz.
What voting and dispositive powers do the Sabby entities report over their REVB shares?
Each reporting person lists 0 shares with sole voting or dispositive power and 605,702 shares with shared voting and shared dispositive power.
What is the event date for the beneficial ownership reported in this Schedule 13G for REVB?
The date of the event that triggered the Schedule 13G filing is 12/31/2025.